The reimbursement of emerging durable/potentially curative cell and gene therapies is likely to be a challenge for the US healthcare market. Considering the pricing of cell- and gene-based therapies approved … Read More
LEAPS Announces Disease Area for Pilot Project
Participants in the first LEAPS Design Lab in July 2018 were tasked with considering disease areas offering the prospect of significant healthcare impact and identifying early practical and technical challenges … Read More
LEAPS project at MIT aims to pilot “learning ecosystem” for patient-centered biomedical innovation
New initiative aims to improve decision-making across biopharmaceutical development and delivery lifecycle CAMBRIDGE, 23 July 2018—The NEWDIGS Initiative at the Massachusetts Institute of Technology (MIT) hosted a Design Lab … Read More
FoCUS responds to HHS “Blueprint” Request for Information
Federal initiative seeks to make access to innovative therapies wider and more financially sustainable On May 16, 2018 the US Department of Health and Human Services (HHS) published a … Read More
Stop-Loss Insurance or Reinsurance for Multiyear Contracts
In previous Research Briefs, we have discussed challenges faced by payers when contemplating using multiyear performance-based contracts. In this brief, we extend the discussion to include additional difficulties that may … Read More
Impact of Patient Mobility on Annuity/Performance-Based Contracting
Spreading payments over time for durable or curative therapies can provide a better alignment between benefits and costs, but creates challenges when patients switch insurance coverage during the contract term. … Read More
Orphan Reinsurer Benefit Managers (ORBMs)
An Orphan Reinsurer Benefit Manager (ORBM) could address the financial challenges (payment timing, therapeutic performance risk, actuarial risk), created by durable/potentially curable gene and cell therapies especially for smaller insurers … Read More
PPD, Evidera join NEWDIGS Initiative at MIT as a Strategic Partner
Collaboration to drive innovation across health care ecosystem WILMINGTON, N.C., May 22, 2018– Pharmaceutical Product Development, LLC (PPD), and its real-world research and market access business unit, Evidera, have joined the Massachusetts Institute … Read More
NEWDIGS in the world, May 2018
NEWDIGS leadership and thinking at recent international gatherings Gigi Hirsch and R. John Glasspool at LIGHT 2018 The second annual LIGHT Forum (Leaders in Global Healthcare and Technology) took place … Read More
NEWDIGS leaders speak at second LIGHT Forum on technology innovation in healthcare
Gigi Hirsch and R. John Glasspool join other innovation leaders to explore the challenges and potential of new technologies for patient care San Mateo, Calif., May 9, 2018 – The … Read More